Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Our purpose is not to endorse or suggest the use of specific therapies, but to provide information about the evidence, or lack thereof, along with potential risks/benefits of various treatment modalities
Wegovy costs Illinois Medicaid approximately $1,200 per patient per month (negotiated rate)
GLP-1RA Lipid-Specific Outcomes While the GLP-1RAs used for weight loss, semaglutide and tirzepatide, have garnered much focus, multiple other GLP-1RA medications have shown positive outcomes on lipid profiles: dulaglutide has shown reduction in total cholesterol and LDL-C [65], liraglutide has shown reduction in LDL-C and ApoCIII [66], and exenatide has shown reduction in LDL-C and total cholesterol and increase in HDL-C [67]
most powerful weight loss program yet Activates both GLP-1 and GIP
US$ 25.53
US$ 27.93
US$ 26.94
